Diagnostic utility of CSF Tau and Aβ 42 in dementia: A meta-analysis

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Agarwal, Rachna ^a   Tripathi, Chandra Bhushan ^a  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN;

CEREBROSPINAL FLUID LEVEL; DEMENTIA; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EFFECT SIZE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 84855562078     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/503293     Document Type: Review

References (27)

1. Agarwal R., Kushwaha S. S., Gupta M., Role of biomarkers in diagnosis of Alzheimer's disease Indian Journal of Medical Biochemistry 2006 10 1 25 30
2. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H. C., Riemenschneider M., de Deyn P. P., Bancher C., Cras P., Wiltfang J., Mehta P. D., Iqbal K., Pottel H., Vanmechelen E., Vanderstichele H., Improved discrimination of AD patients using -amyloid (1-42) and tau levels in CSF Neurology 1999 52 8 1555 1562 (Pubitemid 29220627)
3. Consensus report of the working group on: Biological Markers of Alzheimer's Disease. The Ronald Nacy Reagen Research Institute of the Alzheimer's association the National Institute on Aging Working Group Neurobiology of Aging 1998 19 2 109 116
4. Frank R. A., Galasko D., Hampel H., Hardy J., de Leon M. J., Mehta P. D., Rogers J., Siemers E., Trojanowski J. Q., Biological markers for therapeutic trials in Alzheimer's disease: proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease Neurobiology of Aging 2003 24 4 521 536 (Pubitemid 36519160)
5. Tapiola T., Overmyer M., Lehtovirta M., Helisalmi S., Ramberg J., Alafuzoff I., Riekkinen P., Soininen H., The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease NeuroReport 1997 8 18 3961 3963 (Pubitemid 28027217)
6. Mulder C., Scheltens P., Visser J. J., van Kamp G. J., Schutgens R. B. H., Genetic and biochemical markers for Alzheimer's disease: recent developments Annals of Clinical Biochemistry 2000 37 5 593 607
7. Andreasen N., Minthon L., Davidsson P., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K., Evaluation of CSF-tau and CSF-A 42 as diagnostic markers for Alzheimer disease in clinical practice Archives of Neurology 2001 58 3 373 379 (Pubitemid 32217453)
8. Andreasen N., Vanmechelen E., Vanderstichele H., Davidsson P., Blennow K., Cerebrospinal fluid levels of total-tau, phospho-tau and A 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment Acta Neurologica Scandinavica, Supplement 2003 107 179 47 51
9. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E., Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Molecular and Chemical Neuropathology 1995 26 3 231 245 (Pubitemid 26002016)
10. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K., Cerebrospinal fluid -amyloid (1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Archives of Neurology 1999 56 6 673 680 (Pubitemid 29266465)
11. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., Weber T., Kretzschmar H. A., Poser S., Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neuroscience Letters 1997 225 3 210 212 (Pubitemid 27191632)
12. Verbeek M. M., de Jong D., Kremer H. P. H., Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases Annals of Clinical Biochemistry 2003 40 1 25 40 (Pubitemid 36051407)
13. Andreasen N., Minthon L., Davidsson P., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K., Evaluation of CSF-tau and CSF-A 42 as diagnostic markers for Alzheimer disease in clinical practice Archives of Neurology 2001 58 3 373 379 (Pubitemid 32217453)
14. Huedo-Medina T. B., Snchez-Meca J., Marn-Martnez F., Botella J., Assessing heterogeneity in meta-analysis: Q statistic or I 2 Index? Psychological Methods 2006 11 2 193 206 (Pubitemid 44001277)
15. Arai H., Terajima M., Miura M., Higuchi S., Muramatsu T., Machida N., Seiki H., Takase S., Clark C. M., Lee V. M. Y., Trojanowski J. Q., Sasaki H., Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease Annals of Neurology 1995 38 4 649 652
16. Tapiola T., Lehtovirta M., Ramberg J., Helisalmi S., Linnaranta K., Riekkinen P., Soininen H., CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease Neurology 1998 50 1 169 174 (Pubitemid 28106037)
17. Galasko D., Clark C. M., Chang L., Motter R., Kaye J., Knopman D., Thomas R., Kholodenko D., Schenk D., Lieberburg I., Miller B., Green R., Basherad R., Kertiles L., Boss M. A., Seubert P., High cerebrospinal fluid tau and low amyloid 42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype Archives of Neurology 1998 55 7 937 945 (Pubitemid 28335112)
18. Andreasen N., Vanmechelen E., van de Voorde A., Davidsson P., Hesse C., Tarvonen S., Raiha I., Sourander L., Winblad B., Blennow K., Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study Journal of Neurology Neurosurgery and Psychiatry 1998 64 3 298 305 (Pubitemid 28159831)
19. Kanai M., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro Y., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayashi T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., Shoji M., Longitudinal study of cerebrospinal fluid levels of tau, A 1-40, and A 1-42(43) in Alzheimer's disease: a study in Japan Annals of Neurology 1998 44 1 17 26 (Pubitemid 28323651)
20. Sjgren M., Davidsson P., Wallin A., Granérus A. K., Grundstrm E., Askmark H., Vanmechelen E., Blennow K., Decreased CSF- -amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of -amyloid induced by disparate mechanisms Dementia and Geriatric Cognitive Disorders 2002 13 2 112 118 (Pubitemid 34161156)
21. Grossman M., Farmer J., Leight S., Work M., Moore P., van Deerlin V., Pratico D., Clark C. M., Coslett H. B., Chatterjee A., Gee J., Trojanowski J. Q., Lee V. M. Y., Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease Annals of Neurology 2005 57 5 721 729 (Pubitemid 40628861)
22. de Jong D., Jansen R. W. M. M., Kremer B. P. H., Verbeek M. M., Cerebrospinal fluid amyloid 42 /phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia Journals of Gerontology: Series A 2006 61 7 755 758 (Pubitemid 44148364)
23. Bibl M., Esselmann H., Mollenhauer B., Weniger G., Welge V., Liess M., Lewczuk P., Otto M., Schulz J. B., Trenkwalder C., Kornhuber J., Wiltfang J., Blood-based neurochemical diagnosis of vascular dementia: a pilot study Journal of Neurochemistry 2007 103 2 467 474 (Pubitemid 47498016)
24. Ravaglia S., Bini P., Sinforiani E., Franciotta D., Zardini E., Tosca P., Moglia A., Costa A., Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia Neurological Sciences 2008 29 6 417 423
25. Kapaki E., Paraskevas G. P., Zalonis I., Zournas C., CSF tau protein and -amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population European Journal of Neurology 2003 10 2 119 128 (Pubitemid 36308205)
26. Maddalena A., Papassotiropoulos A., Mller-Tillmanns B., Jung H. H., Hegi T., Nitsch R. M., Hock C., Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to -amyloid peptide 42 Archives of Neurology 2003 60 9 1202 1206 (Pubitemid 37099624)
27. Borenstein M., Higgins L. V., Rothstein H. R., Introduction to Meta-Analysis 2009 New York, NY, USA John Wiley Sons